SCHEMBL2587913

SCHEMBL2587913

Cc1c(P(=S)(c2ccccc2)c2ccccc2)c2ccccc2n1C(=O)NCc1ccc(F)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 7/20 1.00
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 2/20 0.43
TP53 P04637 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CASP3 P42574 1/20 0.42
USP2 O75604 1/20 0.42
ALDH1A1 P00352 2/20 0.41
RAB9A P51151 1/20 0.41
PLA2G1B P04054 1/20 0.41
ATG4B Q9Y4P1 1/20 0.41
ASAH1 Q13510 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2590909 0.92 NPSR1 (1.00) NPSR1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL2593079 0.86 NPSR1 (1.00) NPSR1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL2590676 0.76 NPSR1 (1.00) NPSR1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL2595693 0.67 NPSR1 (1.00) NPSR1MEN1KMT2AALDH1A1RAB9A
SCHEMBL2586617 0.66 NPSR1 (1.00) NPSR1SMN1; SMN2LMNACASP3ASAH1
SCHEMBL2593998 0.66 NPSR1 (0.63) NPSR1MEN1KMT2AALDH1A1
SCHEMBL2587268 0.66 NPSR1 (0.63) NPSR1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL2553685 0.65 HTT (0.65) MEN1KMT2ASMN1; SMN2LMNATP53
SCHEMBL27312101 0.64 NPSR1 (0.54) NPSR1MEN1KMT2ASMN1; SMN2TP53
SCHEMBL2586615 0.64 NPSR1 (0.54) NPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed